FindTrial
Sign In

Study on Heart Failure patients

Assessing the Quality of life in hospitalized patients with heart failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032844
Enrollment
300
Registered
2021-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure

Interventions

None listed

Sponsors

MEDANTA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients meeting with following criteria to be included in the study: 1) Adult patients (but not younger than18 year old) will be included 2) Completion of written informed consent before any assessment is performed. 3) Patients who will be admitted to the hospital or emergency department with a (newly or with existing) diagnosis of heart failure with HFrEF and HFmEF

Exclusion criteria

Exclusion criteria: Patients meeting with following criteria to be excluded from the study: 1) Currently enrolled in another interventional study 2) The patient has recently completed a clinical trial (within past 3 months) that has been terminated and other options (e.g., trial extensions, amendments, etc.) are available to continue a similar treatment, similar tools. 3) Severe cognitive dysfunction or dementia 4) Pregnant or lactating Women. 5) Patients and/or his/her legally acceptable representative not willing to provide voluntary written informed consent for participation in the study

Design outcomes

Primary

MeasureTime frame
To assess the quality of life in heart failure patients using 36 Item Short Form Health Survey (SF-36)Timepoint: 0 month and 3 month—

Secondary

MeasureTime frame
1) To assess the quality of life in heart failure patients using WHOQOL â?? BREF 2) To assess the patient quality of life using EQ-5D-3L questionnaire 3) To estimate the frequency of non-achievement of Guideline-Directed Medical Therapy (GDMT) in real world scenario and evaluate the reasons therein. 4) To evaluate heart rate during admissions and on subsequent follow up 5) To estimate the rate of re-hospitalisation and LVEF 6) Adverse events (AE) or serious adverse events (SAE)Timepoint: 0 month and 3 month—

Countries

India

Contacts

Public ContactDr Sanjay Mittal

Medanta - The Medicity

drsanjaymittal1@gmail.com9910044477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026